purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents

Chapter 1 Post-operative Nausea and Vomiting (PONV) Market Overview
1.1 Post-operative Nausea and Vomiting (PONV) Definition
1.2 Global Post-operative Nausea and Vomiting (PONV) Market Size Status and Outlook (2018-2032)
1.3 Global Post-operative Nausea and Vomiting (PONV) Market Size Comparison by Region (2018-2032)
1.4 Global Post-operative Nausea and Vomiting (PONV) Market Size Comparison by Type (2018-2032)
1.5 Global Post-operative Nausea and Vomiting (PONV) Market Size Comparison by Application (2018-2032)
1.6 Global Post-operative Nausea and Vomiting (PONV) Market Size Comparison by Sales Channel (2018-2032)
1.7 Post-operative Nausea and Vomiting (PONV) Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Post-operative Nausea and Vomiting (PONV) Market
Chapter 2 Post-operative Nausea and Vomiting (PONV) Market Competition by Player
2.1 Global Post-operative Nausea and Vomiting (PONV) Sales and Market Share by Player (2021-2023)
2.2 Global Post-operative Nausea and Vomiting (PONV) Revenue and Market Share by Player (2021-2023)
2.3 Global Post-operative Nausea and Vomiting (PONV) Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Post-operative Nausea and Vomiting (PONV) Market Segment by Type
3.1 Global Post-operative Nausea and Vomiting (PONV) Market by Type
3.1.1 Serotonin Antagonists
3.1.2 Steroids
3.1.3 Dopamine Antagonists
3.1.4 NK-1 Receptor Antagonists
3.1.5 Others
3.2 Global Post-operative Nausea and Vomiting (PONV) Sales and Market Share by Type (2018-2023)
3.3 Global Post-operative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2018-2023)
3.4 Global Post-operative Nausea and Vomiting (PONV) Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Post-operative Nausea and Vomiting (PONV) Market Segment by Application
4.1 Global Post-operative Nausea and Vomiting (PONV) Market by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Channel
4.2 Global Post-operative Nausea and Vomiting (PONV) Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Post-operative Nausea and Vomiting (PONV) Market Segment by Sales Channel
5.1 Global Post-operative Nausea and Vomiting (PONV) Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Post-operative Nausea and Vomiting (PONV) Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Post-operative Nausea and Vomiting (PONV) Market Segment by Region & Country
6.1 Global Post-operative Nausea and Vomiting (PONV) Market Size and CAGR by Region (2018-2032)
6.2 Global Post-operative Nausea and Vomiting (PONV) Sales and Market Share by Region (2018-2023)
6.3 Global Post-operative Nausea and Vomiting (PONV) Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Post-operative Nausea and Vomiting (PONV) Market Share by Type
6.4.3 North America Post-operative Nausea and Vomiting (PONV) Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Post-operative Nausea and Vomiting (PONV) Market Share by Type
6.5.3 Europe Post-operative Nausea and Vomiting (PONV) Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Post-operative Nausea and Vomiting (PONV) Market Share by Type
6.6.3 Asia-Pacific Post-operative Nausea and Vomiting (PONV) Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Post-operative Nausea and Vomiting (PONV) Market Share by Type
6.7.3 South America Post-operative Nausea and Vomiting (PONV) Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Share by Type
6.8.3 Middle East & Africa Post-operative Nausea and Vomiting (PONV) Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Post-operative Nausea and Vomiting (PONV) Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Novartis
7.3 Sanofi
7.4 Helsinn Holding
7.5 Eisai Corporation
7.6 Merck
7.7 GlaxoSmithKline
7.8 Teva Pharmaceutical
7.9 Eli Lilly
7.10 Pfizer
7.11 Johnson & Johnson
7.12 Baxter Healthcare
7.13 Acacia Pharma
7.14 Purdue Pharma
7.15 Heron Therapeutics
7.16 Tesaro
7.17 Ani Pharmaceuticals
7.18 Aphios
7.19 Barr Laboratories
7.20 Especificos Stendhal
7.21 Mundipharma
7.22 Mylan Pharmaceuticals
7.23 OPKO Health
7.24 Orchid Healthcare
Chapter 8 Upstream and Downstream Analysis of Post-operative Nausea and Vomiting (PONV)
8.1 Industrial Chain of Post-operative Nausea and Vomiting (PONV)
8.2 Upstream of Post-operative Nausea and Vomiting (PONV)
8.3 Downstream of Post-operative Nausea and Vomiting (PONV)
Chapter 9 Development Trend of Post-operative Nausea and Vomiting (PONV) (2024-2032)
9.1 Global Post-operative Nausea and Vomiting (PONV) Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Post-operative Nausea and Vomiting (PONV) Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Post-operative Nausea and Vomiting (PONV) Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Post-operative Nausea and Vomiting (PONV) Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Post-operative Nausea and Vomiting (PONV) Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification